Filter
2106
Filtered Results: 2106
Text search:
SARS-CoV-2
Featured
Recommendations
299
New Publications
20
Language
Document type
Guidelines
813
Studies & Reports
370
Fact sheets
320
Manuals
121
Strategic & Response Plan
113
Infographics
101
Resource Platforms
70
No document type
51
Training Material
40
Situation Updates
40
Videos
33
Online Courses
22
Brochures
12
Countries / Regions
Germany
162
Brazil
133
Russia
91
Latin America and the Carribbean
88
Global
83
India
73
Colombia
61
Middle East and North Africa
59
West and Central Africa
51
Mozambique
46
Africa
45
Western and Central Europe
44
East and Southern Africa
43
Angola
40
Argentina
37
Syria
35
Chile
33
Eastern Europe and Central Asia
32
South Africa
31
Peru
30
Yemen
28
Ecuador
27
Ukraine
25
Spain
24
Guinea-Bissau
23
Paraguay
22
South Sudan
19
South–East Asia Region
17
Bolivia
16
Italy
15
Congo, Democratic Republic of
15
Nigeria
14
Kenya
13
El Salvador
12
Burkina Faso
12
Sudan
12
Eastern Europe
11
Mali
11
Niger
10
Venezuela
10
Western Pacific Region
10
Côte d’Ivoire / Ivory Coast
10
Bangladesh
10
Ethiopia
10
Senegal
9
Philippines
9
France
9
Vietnam
9
Benin
8
Congo-Brazzaville
8
Cameroon
7
Portugal
7
Liberia
7
China
6
Malawi
6
Haiti
6
Luxembourg
6
United Kingdom
6
Djibouti
6
Honduras
6
Somalia
6
Madagascar
6
Guatemala
6
Switzerland
5
Mexico
5
Turkey
5
Kazakhstan
5
Afghanistan
5
Saudi Arabia
5
Chad
5
Iraq
5
Tajikistan
4
Thailand
4
Togo
4
Canada
4
Laos
4
Burundi
4
Malaysia
4
Austria
4
Morocco
4
Cambodia
4
Dominican Republic
4
Tanzania
4
Uruguay
4
Tunisia
4
Lebanon
4
Nicaragua
4
Egypt
4
Zambia
4
Indonesia
4
Nepal
3
Ghana
3
Rwanda
3
Iran
3
Uzbekistan
3
Zimbabwe
3
Guinea
3
Jordan
3
Belgium
3
Algeria
3
Uganda
3
Moldova
3
Libya
3
Cuba
3
North Korea
2
Sierra Leone
2
Singapore
2
Kyrgyzstan
2
Mauritania
2
North America
2
South Korea
2
Belarus
2
Israel
2
Georgia
2
Myanmar / Burma
2
North Macedonia
1
Serbia
1
Lesotho
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Asia
1
Ireland
1
Gabon
1
Turkmenistan
1
Japan
1
Mauritius
1
Morocco
1
Southern Africa
1
Papua New Guinea
1
Sri Lanka
1
Greece
1
Palestine
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
1090
Key Resources
59
Clinical Guidelines
46
Public Health
33
Pharmacy & Technologies
29
Women & Child Health
28
Capacity Building
15
Annual Report MEDBOX
2
Toolboxes
COVID-19
1702
Refugee
60
Rapid Response
48
Planetary Health
39
Caregiver
32
TB
28
HIV
15
Global Health Education
14
AMR
13
Mental Health
12
NTDs
12
Health Financing Toolbox
11
NCDs
11
Ebola & Marburg
10
Conflict
10
Pharmacy
9
Polio
7
Zika
6
Disability
2
Cholera
2
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
In this video, you will be provided with an overview of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). This lecture will cover the general characteristics of coronaviruses and the origin of the coronavirus disease 2019 (COVID-19).
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Основные аспекты обеспечения биологической безопасности в лабораторных условиях в связи с распространением вируса SARS-CoV
COVID-19 / SARS-CoV-2 (2019-nCoV)
SARS-CoV-2: a respiratory coronavirus that emerged in late 2019 from live animal markets in Wuhan, China. Bats are the reservoir species.
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
New elements include:
update of contact definitions, in line with latest cont...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
On the 31st December 2019, the World Health Organization (WHO) China country office reported a cluster of pneumonia cases in Wuhan City, Hubei Province of China now known to be caused by a novel virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the causative v...
A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women
Published:April 09, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30285-1
The Lancet Infectious Diseases
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
How concerned should we be about the new variants of SARS CoV 2 which cause COVID-19? Is it unusual for viruses to change and mutate? Do vaccines protect against these variants and what can you do to protect yourself? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
La promoción del lavado de manos es fundamental para minimizar la transmisión de SARS-COV-2 y para salvar vidas. Una de las maneras más frecuentes de trasmisión de SARS-COV-2 es a través de manos contaminadas al tocarse la boca, la nariz y los ojos. También se puede transferir el virus de una ...
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Coronavirus disease 2019 is also known as COVID-19. It is a viral illness that infects the lungs. It is caused by a virus called SARS-associated coronavirus (SARS-CoV-2). This illness was first seen in late 2019 in China and has spread across the world.
The signs of COVID-19 are like the flu, and y...
Public health surveillance for COVID-19: interim guidance 16 December 2020 (Arab Version)
recommended
This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (hereafter referred to as COVID19 surveillance).
Contact tracing – along with robust testing, isolation and care of cases – is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19.
